or
forgot password

    • cancer clinical trials in clarksville, TN

    • Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Carcinoma, Small Cell Lung
    Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Breast Cancer
    Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Carcinoma, Small Cell
    Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Carcinoma, Small Cell Lung, Lung Cancer
    Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Lung Cancer
    Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Neoplasm, Unknown Primary
    Effect of Ketoconazole on the Pharmacokinetics of Vinflunine
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Cancer
    Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Breast Cancer
    Treatment of Head & Neck Cancer With Chemotherapy and Radiation
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Head and Neck Cancer
    Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Esophageal Cancer
    First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Lung Cancer
    A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Prostate Cancer
    Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Multiple Myeloma
    CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Pancreatic Cancer
    Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Breast Cancer
    Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Prostate Cancer
    LBH589 and Gemcitabine in the Treatment of Solid Tumors
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Solid Tumors
    LBH589 Treatment for Refractory Clear Cell Renal Carcinoma
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Renal Cell Carcinoma
    LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid Tumors
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Solid Tumors
    RAD001 Plus Bevacizumab in Metastatic Melanoma
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Metastatic Melanoma
    LBH589 in Refractory Myelodysplastic Syndromes (MDS)
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Myelodysplastic Syndromes (MDS)
    Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Non-Small Cell Lung Cancer
    Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Refractory Malignancy, Solid Tumors
    PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced Malignancies
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Refractory Malignancy, Advanced Malignancies
    Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid Tumors
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Refractory Malignancy
    Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Breast Cancer
    LBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer Patients
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Breast Cancer
    Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts
    Alpha Clinical Research
    Clarksville, Tennessee 37043
    Genital Warts
    Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Non-Small Cell Lung Cancer
    Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Metastatic Pancreatic Cancer
    Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Metastatic Breast Cancer
    Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Gastrointestinal Stromal Tumors
    A Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host Disease
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Chronic Graft-Versus-Host Disease
    Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to Erlotinib
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Non Small Cell Lung Cancer
    5-FU, Aflibercept, and RT for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer
    Tennessee Oncology, PLLC
    Clarksville, Tennessee 37043
    Rectal Cancer